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a b s t r a c t
Leishmaniasis has emerged as the third most prevalent parasite-borne disease worldwide after malaria and
ﬁlariasis, with about 350 million people at risk of infection. Antileishmanial drugs currently available have
various limitations, mainly because of the parasite resistance and side effects. The search of new antileish-
manial drugs is ventured throughout the world.
Purpose: The purpose of this study was to assess the leishmanicidal activity of lipophilic extracts of eight
Hypericum species against promastigote forms of Leishmania (Leishmania) amazonensis.
Material and methods: The dried and powered materials of aerial parts of H. andinum Gleason, H. brevistylum
Choisy, H. caprifoliatum Cham. & Schltdl., H. carinatum Griseb., H. linoides A. St.-Hil., H. myrianthum Cham. &
Schltdl., H. polyanthemum Klotzsch ex Reichardt and H. silenoides Juss. were extracted by static maceration
with n-hexane. Extracts were evaporated to dryness under reduced pressure and stored at −20 °C until bio-
logical evaluation and HPLC analysis. The metabolites investigated were dimeric phloroglucinol derivatives,
benzophenones and benzopyrans. The yields were expressed as mean of three injections in mg of compound
per g of extract (mg/g extract). The effect of Hypericum species on the viability of infective forms of L. (L.)
amazonensiswas determined using a hemocytometer. Amphotericin B was used as a standard drug. The 50%
inhibitory concentration (IC50) values for each extract were determined by linear regression analysis. The
cytotoxic effects of extracts were assessed on peritoneal macrophages of BALB/c mice byMTT assay. The con-
centration that causes 50% of macrophage cytotoxicity (CC50) was determined by linear regression analysis.
The selectivity index (SI) of the extracts was determined considering the following equation: CC50 against
mammalian cells/IC50 against L. amazonensis.
Results: Wedemonstrated thatH. carinatum,H. linoides andH. polyanthemumwere able to kill the parasites in
a dose dependent manner. These extracts presented low cytotoxicity against murinemacrophages. At 48 h of
incubationH. polyanthemum presented signiﬁcant leishmanicidal activitywith a 50% inhibitory concentration
(IC50) of 36.1 μg/ml. The leishmanicidal activity ofH. myrianthumwas signiﬁcantly lower than that presented
by H. polyanthemum, H. carinatum and H. linoides extracts. H. brevistylum and H. caprifoliatum showed sig-
niﬁcant leishmanicidal activity only at high concentrations (500 and 1000 μg/ml), while H. andinum and H.
silenoideswere ineffective.
Conclusion: The promising results demonstrate the importance of the species of the genus Hypericum as
source of compounds potentially useful for the treatment of leishmaniasis.
© 2015 Elsevier GmbH. All rights reserved.
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Parasites of the genus Leishmania cause a spectrum of diseases
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944-7113/© 2015 Elsevier GmbH. All rights reserved.isceral diseases, depending on the parasite species transmitted,
ntrinsic resistance to drugs and mechanisms immune mediated,
uch as the production of oxygen and nitrogen reactive species
Convit et al., 1993; García-Hernández et al., 2012; McMahon-Pratt
nd Alexander, 2004). Leishmaniasis is endemic in 98 countries on
ve continents. At the moment, approximately 350 million peo-
le are considered at risk of contracting leishmaniasis, and about
.2–0.4 million cases of visceral leishmaniasis (VL) and 0.7–1.2
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pmillion cases of cutaneous leishmaniasis (CL) occur each year (Alvar
et al., 2012). Leishmania (Leishmania) amazonensis is able to produce a
wide spectrum of diseases in humans, including localized cutaneous
leishmaniasis (LCL), diffuse cutaneous leishmaniasis (DCL), mucocu-
taneous leishmaniasis (MCL) and VL (Barral et al., 1991).
Despite of the vast amount of research conducted on Leishmania
biology, chemotherapeutic interventions are still far from ideal and
adequate vaccines have yet to be developed (García-Hernández et al.,
2012; Mutiso et al., 2013). The pentavalent antimonials remain the
ﬁrst-line drugs for the treatment of leishmaniasis regardless their
high toxicity, resistance emergency and treatment failure (Sundar,
2001; WHO, 2010). Other drugs such as pentamidine, amphotericin
B and miltefosine have limited use due to their high cost, severe side
effects or resistance (Sánchez-Cañete et al., 2009;WHO, 2010). Plants
are a rich source of new molecules for pharmaceutical purposes, ei-
ther as a source of compounds or as a model for the designing of new
ones (Cragg and Newman, 2013). In the last decades, there has been
a renewed interest in natural products as source of new drugs, in-
cluding anti-infective substances (Butler, 2004; Cragg and Newman,
2013).
Species of the genus Hypericum (Hypericaceae) have been tradi-
tionally used in different parts of the world as antiseptic, diuretic,
stomachic, wound healing and antimicrobial agents (von Poser et al.,
2006), and several reports have conﬁrmed their therapeutical po-
tential. Recently, our group demonstrated that the lipophilic extract
and isolated compounds (benzopyrans HP1, HP2, HP3 and dimeric
phloroglucinol uliginosin B) from H. polyanthemum present antipro-
tozoal activity against Trichomonas vaginalis (Cargnin et al., 2013).
Moreover, extracts of H. lanceolatum and phloroglucinol derivatives
of H. erectum presented pronounced antiplasmodial activity (Moon,
2010; Zofou et al., 2011), while samples ofH. perforatummacerated in
olive oil exerted mild inhibitory activity against Trypanosoma rhode-
siense (Orhan et al., 2013).
Considering the current problems related to antileishmanial drugs
and the increasing need for alternatives thatmay lead to development
of new medicines, this study investigated the leishmanicidal activity
of lipophilic extract of eight Hypericum species against L. amazonensis
and their cytotoxicity on macrophages. To determine the major com-
pounds present in the extracts (Fig. 1), analyses by high performance
liquid chromatography (HPLC) were performed.
Materials and methods
Plant material
Aerial parts of eight Hypericum species in ﬂowering stage were
collected (Table 1). Plants were identiﬁed by Dr. Sérgio Bordignon
(UNILASALLE, RS, Brazil) and voucher specimens were deposited in
the herbarium of Universidade Federal do Rio Grande do Sul (ICN).
Plant collection was authorized by Conselho de Gestão do Patrimônio
Genético (CGEN), Instituto Brasileiro do Meio Ambiente (IBAMA-
003/2008 P 02000.001717/2008-60) and Dirección General Forestal
y de Fauna Silvestre of the Republic of Peru (0147-2010-AG-DGFFS-
DGEFFS).
Extraction procedures
Dried and powered plant materials (50 g) were thoroughly ex-
tracted (5 × 24 h at 25 °C) by static maceration with n-hexane
(5 × 500 ml) (F. Maia, Cotia, São Paulo, Brazil). Extracts were evapo-
rated to dryness under reduced pressure (Rotavapor 8020 Fisatom
R©
)
yielding 1.9% (H. andinum), 3.0% (H. brevistylum), 2.0% (H. capri-
foliatum), 4.0% (H. carinatum), 3.8% (H. linoides), 3.6% (H. myr-
ianthum), 2.5% (H. polyanthemum) and 2.8% (H. silenoides). Thextractswere stored at−20 °C until biological evaluation and analysis
Barros et al., 2013a).
PLC analysis
A Shimadzu liquid chromatograph (Shimadzu Corporation, Kyoto,
apan) equippedwith aDGU-20A5degasser, LC-6ADpumps, SIL-10AD
uto sampler, CTO-20AC columnoven, SPD-20AVUV/VIS detector and
BM-20A communications module was employed. LC Solution 1.24
P2 software was used to record and process the data.
Acetonitrile (CH3CN) and methanol (MeOH) were HPLC grade
Merck, Darmstadt, Germany); triﬂuroacetic acid (TFA) was reagent
rade (Vetec, Duque de Caxias, RJ, Brazil) and distilled water (H2O)
as puriﬁed by a Milli-Q system (Millipore, Bedford, MA, USA). The
eparations were performed with Waters Nova Pack C18 column
4 μm, 3.9 mm × 150 mm) and Waters Nova-Pack C18 60 A˚ guard
olumn (3.9 mm × 20 mm). Benzophenones (1 = cariphenone
; 2 = cariphenone B) and benzopyrans (3 = 6-isobutyryl-5,7-
imethoxy-2,2-dimethyl-benzopyran (HP1); 4 = 7-hydroxy-6-
sobutyryl-5-methoxy-2,2-dimethyl-benzopyran (HP2); 5 = 5-
ydroxy-6-isobutyryl-7-methoxy-2,2-dimethyl-benzopyran (HP3))
ere eluted with an isocratic mobile phase system consisting of
H3CN:H2O (60:40, v/v) and detection at 270 nm. Dimeric phloroglu-
inols (6 = hyperbrasilol B; 7 = japonicin A; 8 = uliginosin B) were
lso eluted with an isocratic mobile phase system but consisting
f CH3CN:H2O (95:5, v/v) containing 0.01% of TFA and detection at
20 nm.
The extracts, completely dissolved in MeOH, were ﬁltered
0.22 μmpore size,Merck) andanalyzedat roomtemperature (25 °C),
t a ﬂow rate of 1 ml/min. The injection volume was of 20 μl.
eaks were identiﬁed by comparison of their retention times (Rt)
1 = 8.0 min; 2 = 6.2 min; 3 = 8.2 min; 4 = 11.5 min; 5 = 19.4 min;
= 8.8 min; 7 = 5.7 min; 8 = 7.3 min) and co-injection with authen-
ic standards isolated from Hypericum species (benzophenones 1 and
from H. carinatum; benzopyrans 3 – 5 from H. polyanthemum;
imeric phloroglucinol 6 from H. caprifoliatum, 7 and 8 from H. myr-
anthum) (Bernardi et al., 2005; Dall’agnol et al., 2005; Ferraz et al.,
001; Nör et al., 2004). The identity and purity of compounds were
onﬁrmed by 1H-NMR spectroscopy (Eft-60
R©
, Anasazi Instruments).
alibration curves described by Barros et al. (2013a,b) were used to
uantify themetabolites. Thebenzophenone2anddimericphloroglu-
inols 6 and 7 were determined with 1 and 8 calibration curves, re-
pectively. The yields were expressed as mean of three injections in
g of compound per g of extract (mg/g extract).
. (L). amazonensis culture
The MHOM/BR/73/M2269 strain of L. (L). amazonensis were rou-
inely isolated from draining popliteal lymph node of footpad le-
ions of infected BALB/c mice and maintained as promastigotes in
199 medium containing 40 mM of 4-(2-hydroxyethyl) piperazine-
-ethanesulfonic acid sodium salt (HEPES), 0.1 mM adenine, 7.7 mM
emin, 10% (v/v) heat-inactivated fetal bovine serum (FBS), 50 U/ml
f penicillin and 50 μg/ml of streptomycin. Cultures were incubated
t 26 °C, and cells were kept at densities ranging between 5 × 105
nd 3 × 107 parasites/ml (Romão et al., 2006). All experimental pro-
edures were performed in accordance with the guidelines of the
ational Institute of Health and Brazilian Society for Science on Ani-
als of Laboratory with the approval of local Ethics Committee from
ederal University of Health Sciences of Porto Alegre (process number
1-061).
etermination of leishmanicidal activity in vitro
Promastigote forms of L. amazonensis (3 × 106 on stationary
hase) were plated in 96 well microtiter plates in four replicates
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Fig. 1. Constituents investigated in n-hexane extracts of the Hypericum species.
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tnd incubated with M199 medium supplemented with 10% FBS
n the presence or absence Hypericum extracts (0–1000 μg/ml)
or 48 h. Amphotericin B (Sigma, USA) at 4 μg/ml was used as
tandard antileishmanial drug (100% of mortality). Control cells
ere incubated with M199 medium containing less than 0.05% of
olysorbate 80 (Tween 80). Parasites viability was evaluated from
otility after 48 h and cell density was determined using a hemo-
ytometer. The survival rate was calculated according to the for-
ula: percentage survival = (average number of viable parasites in
reated group/average number of viable untreated parasites) × 100.
he 50% inhibitory concentration (IC50) values for each extract were
etermined by linear regression analysis using GraphPad Software,
ersion 5.0.
acrophages viability
The macrophages viability was measured by a colorimetric as-
ay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro-
ide (MTT). Peritoneal macrophages were harvested from BALB/c
ice which 3 days previously had been injected i.p. with 2 ml of
terile thioglycollate solution (3% w/v in PBS). The cells were plated
t 2 × 105 cells/0.2 ml in RPMI 1640 plus 10% FBS, 100 U/ml peni-
illin and streptomycin (100 μg/ml) in 96 well microtiter plates and
ere incubated overnight at 37 °C in an atmosphere of 5% CO2.
hen, plates were washed prior to being cultured for 44 h at 37 °C
n RPMI or medium plus different concentrations of Hypericum ex-
racts (0–1000 μg/ml). Subsequently, MTT (5 mg/ml in PBS) was
dded (20 μl/well) and incubations were continued 4 h afterwards.
he purple formazan product which is formed by the action of mi-
ochondrial enzymes in living cells was solubilized by addition of
cidic isopropanol, and the absorbance at 570 nm measured using a
pectramax M2 (Pal et al., 2011; Romão et al., 1999). The concentra-
ion of extract that causes 50% of macrophage cytotoxicity (CC50) wasTable 1
Collection data of the Hypericum species.
Species (voucher number)
H. andinum Gleason (Ccana-Ccapatinta et al. 05)
H. brevistylum Choisy (Ccana-Ccapatinta et al. 03)
H. caprifoliatum Cham. & Schltdl. (Bordignon et al. 2287)
H. carinatum Griseb. (Bordignon and Ferraz 2309)
H. linoides A. St.-Hil. (Bordignon et al. 3317)
H. myrianthum Cham. & Schltdl. (Bordignon et al. 3059)
H. polyanthemum Klotzsch ex Reichardt (Bordignon et al., 3118)
H. silenoides Juss. (Ccana-Ccapatinta et al. 01)etermined by linear regression analysis using GraphPad Software,
ersion 5.0. The selectivity index (SI) of the extracts was deter-
ined considering the following equation: CC50 against mammalian
ells/IC50 against L. amazonensis.
tatistical analysis
The statistical analysis was determined by one-way ANOVA
ollowed by Bonferroni’s test. The analyses were performed with
raphPad Software and values of p < 0.05 were considered signif-
cant. All experiments were performed at least three times and in
uadruplicate.
esults
The addition of H. linoides, H. carinatum and H. polyanthemum
xtracts directly to promastigotes of L. amazonensis resulted in dose-
ependent parasite killing (Fig. 2A). After 48 h incubation, H. polyan-
hemum at concentrations 31.2 and 62.5 μg/ml showed moderate to
igh leishmanicidal activity reducing the parasite viability in an order
f 27.5% and 98.8%, respectively (Fig. 2A). The IC50 value of H. polyan-
hemum was calculated to be 36.1 μg/ml (Table 2). As illustrated in
ig. 2C and D, H. polyanthemum at 125 μg/ml led to total lysis of the
arasites. In addition, itwas observed thatH. carinatum andH. linoides
t 62.5 μg/ml killed the parasite in 42.2% and 31.6%, respectively
hen compared to the control group (Fig. 2A). As expected, ampho-
ericin B, the reference antileishmanial drug, was the most active
gainst L. amazonensis (IC50 48 h = 0.12 μg/ml) (data not shown).
The effect on the viability of macrophages of the most active ex-
racts (H. carinatum, H. linoides and H. polyanthemum) against in-
ective forms of L. amazonensis was also investigated. In general,
hese extracts showed low cytotoxicity (Fig. 2B). It was veriﬁed
hat the 50% cytotoxic concentration (CC50), and selectivity indexCollection locality (harvest)
Amparaes, Cuzco, Peru (May, 2008)
Pumahuanca, Cuzco, Peru (May, 2008)
Porto Alegre, RS, Brazil (October – December, 2008)
Glorinha, RS, Brazil (October – December, 2008)
São José dos Ausentes, RS, Brazil (October – December, 2008)
Paraíso do Sul, RS, Brazil (October – December, 2008)
Caçapava do Sul, RS, Brazil (October – December, 2008)
Pumahuanca, Cuzco, Peru (May, 2008)
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Fig. 2. Leishmanicidal and cytotoxic activities ofH. polyanthemum,H. carinatum andH. linoides extracts. Promastigote formsof L. amazonensis (A) andperitonealmurinemacrophages
(B) were treated with medium or Hypericum extracts (15.6–1000 μg/ml) for 48 h. Leishmania survival was determined using a hemocytometer and the macrophages viability
by the MTT assay. L. amazonensis integrity after exposure to medium or H. polyanthemum at 125 μg/ml can be visualized in panels C and D, respectively (panoptic stain – 400×
magniﬁcation). Data are reported as means ± SEM of four replicates and are representative of three experiments. Statistically signiﬁcant different with ∗p < 0.05 compared with
control (ANOVA followed by Bonferroni’s test).
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svalues (CC50/IC50) ranged from 118.6 to 144.7 μg/ml and 1.2 to 4,
respectively (Table 2).
The leishmanicidal activity of H. myrianthum was signiﬁcantly
lower than those found for H. polyanthemum, H. carinatum and H.
linoides independently of the tested concentration (data not shown).
Hypericum brevistylum and H. caprifoliatum showed signiﬁcant leish-
manicidal activity only at high concentrations. These extracts at
500 μg/ml were able to reduce the viability in an order of 90% and
55%, respectively. In addition, the concentration of 1000 μg/ml in-
duced 100% and 82.5% of mortality, respectively. In contrast, H. and-
inum and H. silenoides did not show signiﬁcant leishmanicidal effect
even at the highest concentration (data not shown).
The results of HPLC analysis are shown in Table 3. HPLC proﬁle
of the most active extract (H. polyanthemum) can be visualized in
Fig. 3. All the plants presented the dimeric phloroglucinol 8. The ex-
tracts of H. linoides and H. myrianthum presented the highest concen-
tration of 6 and 7, respectively. Conﬁrming previous reports (Barros
et al., 2013b; Bernardi et al., 2005; Cargnin et al., 2013; Ferraz et al.,
2001), benzophenones 1 and 2 were found exclusively in H. car-
inatum, while benzopyrans 3, 4 and 5 were detected only in H.
polyanthemum.Table 2
Leishmanicidal activity and macrophages cytotoxicity of extracts of Hypericum species at 48
Hypericum species IC50
a, μg/ml (95% CI)
H. polyanthemum 36.12 (30.25–43.13)
H. carinatum 64.99 (51.90–81.38)
H. linoides 111.9 (65.04–192.70)
a IC50: concentration of extract that causes 50% of mortality of L. amazonensis.
b CC50: concentration of extract that causes 50% of macrophage cytotoxicity.
c 95 CI: 95% conﬁdence interval.
d SI: selectivity index, calculated as ratio of CC50 for macrophage/IC50 for L. amazonensis.iscussion
This is the ﬁrst study reporting the leishmanicidal activity for Hy-
ericum species on L. amazonensis. Here, it was demonstrated that
epending on the dose, the lipophilic extracts of H. polyanthemum, H.
arinatum,H. linoides,H. myrianthum,H. caprifoliatum andH. brevisty-
umwere able to kill infective forms of L. amazonensis, one of themain
gent of cutaneous leishmaniasis in the world (Carvalho et al., 1994;
rança-Costa et al., 2012). The current treatment of leishmaniasis
resents problems such as drug resistance, variable or low eﬃcacy,
igh cost, side effects, besides others (Sánchez-Cañete et al., 2009;
undar, 2001; WHO, 2010). Considering this, the search for new ac-
ive compoundsmay lead to the discovery ofmore eﬃcientmedicines
or the treatment of leishmaniasis. It is interesting to note that dif-
erent extracts of Hypericum spp. present activity against protozoa as
lasmodium sp., Trypanosoma sp. and Trichomonas sp. (Cargnin et al.,
013;Moon, 2010; Orhan et al., 2013; Verotta et al., 2007; Zofou et al.,
011), conﬁrming this potential.
Signiﬁcant differences in the leishmanicidal activity of ex-
racts obtained from different Hypericum species were ob-
erved. Hypericum polyanthemum presented the highest activityh.
CC50
b, μg/ml (95% CIc) SId
144.7 (91.68–228.3) 4
118.6 (87.34–161) 1.8
137.1 (108.4–173.4) 1.2
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Table 3
Content of the major compounds present in the lipophilic extract of the investigated Hypericum species.
Hypericum species Compounds (mg/g extract)
1 2 3 4 5 6 7 8
H. andinum – – – – – – – 16.60
H. brevistylum – – – – – 1.08 – 68.98
H. caprifoliatum – – – – – – 2.79 0.60
H. carinatum 0.83 5.76 – – – – – 16.48
H. linoides – – – – – 13.98 14.41 1.92
H. myrianthum – – – – – – 70.51 35.97
H. polyanthemum – – 356.99 426.84 109.77 – – 0.54
H. silenoides – – – – – – – 42.27
1 = cariphenone A; 2 = cariphenone B; 3 = 6-isobutyryl-5,7-dimethoxy-2,2-dimethyl-benzopyran (HP1); 4 = 7-hydroxy-6-isobutyryl-5-methoxy-2,2-dimethyl-benzopyran
(HP2); 5 = 5-hydroxy-6-isobutyryl-7-methoxy-2,2-dimethyl-benzopyran (HP3); 6 = hyperbrasilol B; 7 = japonicin A; 8 = uliginosin B; –, not detected.
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(H. polyanthemum > H. carinatum > H. linoides > H. myrianthum > H.
revistylum > H. caprifoliatum). It is noteworthy to notice that this is
he only species that accumulate benzopyrans 3–5 (Table 3, Fig. 3)
Barros et al., 2013a,b; Cargnin et al., 2013; Ferraz et al., 2001).
In the present study, the IC50 values ofH. polyanthemum,H. carina-
um andH. linoides n-hexane extracts against promastigotes of L. ama-
onensis ranged from 36 to 112 μg/ml. Recently, Cargnin et al. (2013)
emonstrated that the supercritical ﬂuid extract of H. polyanthemum
t 206.98 μg/ml reduced the viability of Trichomonas vaginalis in 50%,
hile its main isolated compounds (3, 4, 5 and 8) at 62.5 μg/ml de-
reased the parasite viability in 50%, 20%, 10% and50%, respectively. In
he present study, at 62.5 μg/ml the n-hexane extract ofH. polyanthe-
um caused an inhibition of 90% in the Leishmania viability, showingig. 3. HPLC proﬁle of n-hexane extract of Hypericum polyanthemum. Stationary phase: Wate
uard column (3.9 mm × 20 mm). (A) Isocratic elution (60% CH3CN, 40% H2O) and detection
95% CH3CN, 5% H2O, 0.01% TFA) and detection at 220 nm. 8, Uliginosin B (7.3 min).n IC50 value of 5.7 times lower. It is important to consider that the
ifference in the susceptibility of these pathogens might be due to a
igher selectivity of H. polyanthemum extract against L. amazonensis
nd/or a synergistic effect of its compounds. In this context, Grivicich
t al. (2008) demonstrated that in association, 3, 4 and 5 were more
otent in inhibiting the growth of U-373 MG cells, a glioblastoma
ell line, when compared to the independent effect of each isolated
ne. Thus, such compounds seem to be very interesting candidates to
uture studies against protozoa pathogens.
According to the literature, extracts and more lipophilic com-
ounds tend to favor the anti-protozoa activity (Cargnin et al., 2013;
aciel-Rezende et al., 2013). Alkyl-substituted benzophenones, for
xample, demonstrated to be more active than their hydroxylatedrs Nova Pack C18 column (4 μm, 3.9 mm × 150 mm) andWaters Nova-Pack C18 60 A˚
at 270 nm. 3, HP1 (8.2 min); 4, HP2 (11.5 min); 5, HP3 (19.4 min). (B) Isocratic elution
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Zprecursors suggesting that an increase in lipophilicity of these
compounds could facilitate the protozoa membrane permeation
(Maciel-Rezende et al., 2013). Similar hypothesis was conﬁrmed by
Cargnin et al. (2013) that demonstrated the action of 3, 4, 5 and 8 on
membranes of T. vaginalis. Alterations in respiratory chain of L. dono-
vani were also observed to benzophenone-derived bisphosphonium
salts with intermediate hydrophobicity (Luque-Ortega et al., 2010).
Considering the wide occurrence of phloroglucinol derivatives
in Hypericum, other species of the genus should be investigated.
The well-studied species H. perforatum, for example, contains very
lipophilic phloroglucinol derivatives such as hyperforin and adhyper-
forin that were not still investigated for leishmanicidal activity.
Conclusion
The results of the present research exhibit for the ﬁrst time thatH.
polyanthemum, H. carinatum and H. linoides present signiﬁcant activ-
ity against L. amazonensis. Under this point of view H. polyanthemum
extract might be investigated as a promising candidate for antileish-
manial treatment. Further studies are being conducted to elucidate
the mechanism of action.
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